"Behavior Drugs Given to Four-Year-Olds Prompt Calls for Inquiry": So ran a front-page news story in yesterday's Guardian, one of Britain's leading newspapers. "Children as young as four are being given Ritalin-style medication for behavioral problems in breach of NHS [National Health Service] guidelines, the Guardian has discovered, prompting the leading psychological society to call for a national review."

Why is it difficult to imagine a similar headline in, say, USA Today? After all, we have copious evidence that toddlers less than one-year-old have been given even-more powerful drugs in this country, including atypical antipsychotics. In March 2009, as I've noted before, Florida's St. Petersburg Times reported that in 2007 23 infants less than one-year-old were given antipsychotics.

That newspaper's title for the story, "Approval Process Lowers the Number of Kids on Atypical Prescriptions," was meant to reassure readers that the numbers were slipping: Only 5 one-year-olds were prescribed the drugs the following year, the paper reports. Similarly, "only" 107 three-year-olds, 268 four-year-olds, and 437 five-year-olds were given the powerful antipsychotics in 2008.

Concerning the overmedication of America's toddlers and children, can we not have a national investigation into similar "breaches of . . . guidelines" here, too?


Related links:

"'The bipolar child is a purely American phenomenon': An Interview with Philip Dawdy," Psychology Today (April 7, 2009).

"Child's Ordeal Shows Dangers of Antipsychotic Drugs," New York Times (September 1, 2010).

"Medicating Children: Why Controversy Still Flares over 'Early Detection,'" Psychology Today (September 2, 2010).

Recent Posts in Side Effects

Faulty Reporting on ADHD

Newspaper of record criticized for its tardy response to overmedicalization.

“Side Effects” Turns A Million

Thanks to all my readers.

New DSM-5 Disorder Spurs FDA Drug Approval, Expanded Market

Drug-maker’s challenge: “increase the numbers of patients diagnosed.”

Personalized Genomics, Data-Hoarding, and Drug Companies

How do genetic-testing companies make money?

Tackling Childhood Obesity: What Works, What Doesn’t

How childhood obesity became a global problem.

Ebola, a Promising Serum, and Kent Brantly’s Recovery

Is Kent Brantly’s recovery owing to medicine, religious faith, or both?